Utah Medical Products, Inc. (UTMD) — Financial statements
Income statement, balance sheet, and cash flow for Utah Medical Products, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 39↓5.8% | 41↓18.6% | 50↓3.9% | 52↑6.6% | 49 | |
| Cost of Revenue | 19↑11.2% | 17↓17.0% | 20↑0.5% | 20↑10.7% | 18 | |
| Gross Profit | 20↓17.7% | 24↓19.6% | 30↓6.7% | 32↑4.1% | 31 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.67↓17.8% | 0.81↑45.2% | 0.56↑13.6% | 0.49↓6.3% | 0.53 | |
| General & Administrative Expenses | 0.00↓100.0% | 4↓66.7% | 11↑5.9% | 10↑3.1% | 10 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 2↑12.8% | 2↑11.8% | 2↑6.6% | 1 | |
| SG&A Expenses | 8↑40.2% | 6↓56.2% | 13↑6.6% | 12↑3.5% | 12 | |
| Other Expenses | 0.00↓100.0% | 4 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 8↓19.7% | 11↓20.5% | 13↑6.9% | 12↑3.1% | 12 | |
| Total Costs & Expenses | 27↓0.7% | 27↓18.4% | 33↑2.9% | 32↑7.7% | 30 | |
| Operating Results | ||||||
| Operating Income | 11↓16.1% | 14↓19.0% | 17↓15.2% | 20↑4.8% | 19 | |
| Depreciation & Amortization | 3↑6.5% | 3↓56.5% | 6↓10.1% | 7↓2.8% | 7 | |
| EBITDA | 17↑3.8% | 16↓33.6% | 25↓7.9% | 27↑2.7% | 26 | |
| EBIT | 14↑3.8% | 14↓26.3% | 18↓6.8% | 20↑4.8% | 19 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 3 | 0.00↓100.0% | 0.66↑298.2% | 0.17 | |
| Interest Income | 0.00↓100.0% | 3 | 0.00↓100.0% | 0.66↑298.2% | 0.17 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | -3 | 0.00↑100.0% | -2 | 0.00 | 0.00 | |
| Other Income / Expenses | 3↓15.6% | 3↓3.1% | 3↑281.1% | 0.87↑380.1% | 0.18 | |
| Income Before Tax | 14↓16.0% | 17↓16.4% | 20↓2.8% | 21↑8.4% | 19 | |
| Income Tax Expense | 3↓3.6% | 3↓15.2% | 3↓17.5% | 4↓2.0% | 4 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 11↓18.7% | 14↓16.6% | 17↑1.0% | 16↑11.4% | 15 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 11↓18.7% | 14↓16.6% | 17↑1.0% | 16↑11.4% | 15 | |
| Bottom-Line Net Income | 11↓18.7% | 14↓16.6% | 17↑1.0% | 16↑11.4% | 15 | |
| EPS (Basic) | 3.41↓13.9% | 3.96↓13.3% | 4.57↑0.9% | 4.53↑11.9% | 4.05 | |
| EPS (Diluted) | 3.48↓12.1% | 3.96↓13.3% | 4.57↑1.1% | 4.52↑11.9% | 4.04 | |
| Weighted Average Shares | 3↓5.5% | 4↓3.7% | 4↓0.0% | 4↓0.3% | 4 | |
| Weighted Average Diluted Shares | 3↓7.5% | 4↓3.7% | 4↓0.2% | 4↓0.5% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.